Suppr超能文献

硝苯地平与普萘洛尔对肥厚性梗阻性心肌病患者的血流动力学影响。

Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.

作者信息

Landmark K, Sire S, Thaulow E, Amlie J P, Nitter-Hauge S

出版信息

Br Heart J. 1982 Jul;48(1):19-26. doi: 10.1136/hrt.48.1.19.

Abstract

The haemodynamic effects of nifedipine, propranolol, and the combined administration of the two drugs were studied in 12 patients with hypertrophic obstructive cardiomyopathy. The combined administration of nifedipine and propranolol appeared to be superior to that of nifedipine alone. The spontaneous heart rate was reduced in most cases after nifedipine plus propranolol, and at atrial pacing the following results were obtained: left ventricular peak systolic pressure was reduced from 200 +/- 39 to 157 +/- 30 mmHg; a positive correlation was found between the pre-drug left ventricular end-diastolic pressure and the magnitude of reduction in left ventricular end-diastolic pressure; systolic blood pressure was reduced from 125 +/- 31 to 111 +/- 27 mmHg, and total peripheral resistance was reduced from 1403 +/- 307 to 1160 +/- 209 dyne s-1 cm-5. The combined administration reduced the resting left ventricular outflow gradient from 76 +/- 19 to 45 +/- 26 mmHg, while cardiac index was left unchanged. The effects on mean pulmonary arteriolar resistance and mean pulmonary arteriolar resistance and mean pulmonary capillary venous pressure were in most cases slight and insignificant. The results indicate an improved haemodynamic condition in patients with hypertrophic obstructive cardiomyopathy after the combined administration of nifedipine and propranolol: a treatment that might provide a new and useful alternative to already existing medication.

摘要

对12例肥厚性梗阻性心肌病患者研究了硝苯地平、普萘洛尔以及两药联合应用的血流动力学效应。硝苯地平和普萘洛尔联合应用似乎优于单独使用硝苯地平。硝苯地平加普萘洛尔治疗后多数病例的静息心率降低,心房起搏时获得以下结果:左心室收缩压峰值从200±39mmHg降至157±30mmHg;用药前左心室舒张末期压力与左心室舒张末期压力降低幅度之间呈正相关;收缩压从125±31mmHg降至111±27mmHg,总外周阻力从1403±307达因·秒·厘米⁻⁵降至1160±209达因·秒·厘米⁻⁵。联合用药使静息左心室流出道压差从76±19mmHg降至45±26mmHg,而心脏指数未变。多数情况下,联合用药对平均肺动脉阻力、平均肺毛细血管静脉压的影响轻微且无统计学意义。结果表明,硝苯地平和普萘洛尔联合应用后肥厚性梗阻性心肌病患者的血流动力学状况得到改善:这种治疗方法可能为现有药物治疗提供一种新的、有用的替代方案。

相似文献

4
Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Am J Cardiol. 1985 Jan 25;55(3):185B-195B. doi: 10.1016/0002-9149(85)90630-7.
5
Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Chest. 1983 Apr;83(4):704-6. doi: 10.1378/chest.83.4.704.
7

引用本文的文献

5
Clinical decisions in the management of the cardiomyopathies.心肌病治疗中的临床决策
Drugs. 1989 Dec;38(6):988-99. doi: 10.2165/00003495-198938060-00009.

本文引用的文献

2
ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE.异丙肾上腺素与心血管功能
Am J Med. 1964 Oct;37:514-25. doi: 10.1016/0002-9343(64)90065-8.
5
Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
N Engl J Med. 1980 Oct 2;303(14):801-3. doi: 10.1056/NEJM198010023031407.
6
Hypertrophic cardiomyopathy: a disease in search of its own identity.
Am J Cardiol. 1980 Jan;45(1):177-80. doi: 10.1016/0002-9149(80)90236-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验